Pretreatment with standard-dose intravenous methylprednisolone does not improve outcomes in newly diagnosed immune thrombocytopenia (ITP).
Essilini A, Comont T, Germain J, Brun N, Dingremont C, Castel B, Arista S, Madaule S, Sailler L, Lapeyre-Mestre M, Beyne-Rauzy O, Godeau B, Adoue D, Moulis G; CARMEN investigators group.
Essilini A, et al. Among authors: adoue d.
Eur J Haematol. 2018 May;100(5):412-418. doi: 10.1111/ejh.13032. Epub 2018 Mar 12.
Eur J Haematol. 2018.
PMID: 29360249